Last checked at 19 Jun 2014 11:00
Deltex Medical Group plc("Deltex Medical" or "the Company")
Director/PDMR Share Dealing
19 June 2014 - Deltex Medical Group (AIM: DEMG), the global leader in oesophageal Doppler monitoring, announces that it has been notified that Paul Mitchell, Finance Director transferred a total of 86,750 ordinary shares of 1p each in the Company ("Ordinary Shares") into his Self Invested Personal Pension on 18 June 2014. This was effected by way of a sale of 86,750 Ordinary Shares held by Paul Mitchell at a price of 10.50 pence per Ordinary Shares. His pension fund then purchased 86,750 Ordinary Shares at a price of 10.55 pence per Ordinary Shares.
As a result of this transaction, Paul Mitchell's total beneficial holding remains unchanged at 352,831 Ordinary Shares representing 0.17% of the total issued ordinary share capital of the Company.
For further information, please contact:
Deltex Medical Group plc | 01243 774 837 |
Nigel Keen, Chairman | investorinfo@deltexmedical.com |
Ewan Phillips, Chief Executive | |
Paul Mitchell, Finance Director | |
Nominated Adviser & Broker | |
Arden Partners plc | 020 7614 5900 |
Chris Hardie | |
Joint Broker | |
Zeus Capital Limited | 020 7533 7727 |
Dominic Wilson | |
John Goold | |
Financial Public Relations | |
Newgate Threadneedle | 020 7653 9850 |
Caroline Forde | |
Heather Armstrong |